What could be expected after fifteen years of amiodarone therapy?

European Journal of Dermatology

Volumn 18, Issue 2, 2008, Pages 202-203

  Radman, Maja ^a   Tomas, Davor ^b   Situm, Mirna ^b   Solter, Miljenko ^b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; LEVOTHYROXINE;

AGED; ANAMNESIS; CASE REPORT; CHEEK; CHIN; FACE; FOLLOW UP; HAND; HEART ATRIUM FIBRILLATION; HUMAN; HYPERPIGMENTATION; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; KERATOPATHY; LETTER; LONG TERM CARE; MALE; MICROSCOPY; NOSE; PHYSICAL EXAMINATION; PUNCH BIOPSY; SKIN DISCOLORATION;

AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DIAGNOSIS, DIFFERENTIAL; FACIAL DERMATOSES; HUMANS; HYPERPIGMENTATION; HYPOTHYROIDISM; MALE;

EID: 42349103602     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0372     Document Type: Letter

References (6)

1. Raptis L, Papathanasion H, Pappas G, Akritidis N. It's all in the face: amiodarone - induced myxedema and skin pigmentation. Eur J Dermatol 2006; 16 (5): 590-1.
2. Klein AD, Pardo RJ, Gould E, Kerdel F. Blue-gray discoloration of the face. Amiodarone-induced cutaneous hyperpigmentation. Arch Dermatol 1989; 125: 17-421.
3. Maoz KBA, Brenner S. Amiodarone-induced skin pigmentation and multiple BCCs. J Am Acad Dermatol 2007; 56 (2): AB151.
4. Martino E, Bartalena L, Bogazzi F, et al. The effects of amiodarone on the thyroid. Endocr Rev 2001; 22: 240-55.
5. Chilov MN, Franzco CM, Franzco FB. Unilateral amiodarone keratopathy. Clin Exp Ophthalmol 2005; 33 (6): 656-8.
6. Singh BN. Amiodarone: a multifaceted antiarrhythmic drug. Curr Cardiol Rep 2006; 8 (5): 349-55.